Boston Scientific (BSX) Any Comments??? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Boston Scientific (BSX) Any Comments???

BSX 100.55

+0.2%

Oct 30 3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Lighthouse who wrote (783)	6/18/2002 1:52:07 PM
From: Lighthouse	Read Replies (2) of 798

This stock again has appeal top me; however, has anyone got an idea of the contingent liability of the Medinol lawsuit? The GDT/Cook/BSX June 13th court decision could not have gone better for BSX. The judge gave them everything they wanted. GDT may have to pay BSX through the nose in 2003 and 2004 to license paclitaxel. GDT is hoping that everolimus will be ready by 2005 and then they can get out of any licensing deal weith BSX. BUT those two years are going to be expensive. The Medinol liability is a big unknown. Anyone want to venture a best and worst case scenario? Best: $0 unlikely in my opinion. Worst: Lost profits and permanent company impairment. Punative damages. Tally it up and the number could be over $1 billion. Any ideas out there? Cheers,

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next